Active substances
Acellular pertussis + Diphtheria toxoid + Tetanus toxoid
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ADACEL 0.5 ml suspension for injection | 5,2,2.5 LfU,µg,LfU | Suspension · Intramuscular use | 1 Vial | SAR 69.60 | Biological · Prescription | SANOFI PASTEUR | Valid |
| Adacel | 2,5,2.5 LfU,LfU,µg | Suspension for injection · Intramuscular use | 1 Pre-filled syringe | SAR 83.50 | Biological · Prescription | SANOFI PASTEUR | Valid |
| TRIPACEL VACCINE | 15,5,23 LfU,LfU,µg | Suspension for injection · Intramuscular use | 1 Vial | SAR 69.60 | Biological · Prescription | SANOFI PASTEUR | Valid |
Indications — CHI Daman Drug Formulary
ADULT IMMUNIZATION; BURN MANAGEMENT; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)-PREVENTION OF EXACERBATIONS; MATERNAL AND CHILD HEALTHCARE- IMMUNIZATION FOR MOTHER AND CHILD; TRAVEL IMMUNIZATION
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.